The description of four distribution patterns—Pattern I (negative scan), Pattern II (mild temporal binding only), Pattern III (AD-like binding), Pattern IV (non-AD-like) [106]—seems promising in describing the heterogeneity of tauopathy distribution (and subsequently Tau tracers’ uptake) in the dementia field. The gene discussed is MAPT; the disease is dementia.